VAERS reports by lot

Moderna COVID-19 lot 040AZ1A: VAERS reports

36 VAERS reports list lot 040AZ1A as a Moderna COVID-19 vaccine, received between 2021-03-06 and 2024-07-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
17%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3423%
Injection-site / Local reaction2718%
Neurological2014%
Allergic / Anaphylactic128%
Gastrointestinal128%
Cardiac / Cardiovascular107%
Dermatological (non-injection-site)107%
Respiratory96%
Musculoskeletal64%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated21%
Psychiatric / Neuropsychiatric21%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan4
Tennessee3
Florida3
New York3
Ohio2
Wisconsin2
California2
Louisiana2
Alabama2
Georgia1
Texas1
Arizona1

Reports by month received

2021-0311
2021-047
2021-051
2021-061
2021-072
2021-086
2021-091
2022-023
2022-031
2022-061
2023-021
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.